Evolution from placenta previa to Type‐3 vasa previa

Oyelese, Y.

doi:10.1002/uog.27505

Ultrasound in Obstet & Gyne

2024

DOI: 10.1002/uog.27505

|View full text |Cite

Evolution from placenta previa to Type‐3 vasa previa

Y. Oyelese

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article4

Relationship

Self Cite0

Independent4

Authors

Journals

Cited by 4 publications

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Challenging common misconceptions in vasa previa screening and diagnosis

Srinivasan,

Daly‐Jones,

Oyelese

et al. 2024

Ultrasound in Obstet & Gyne

View full text Add to dashboard Cite

Challenging common misconceptions in vasa previa screening and diagnosis

Srinivasan,

Daly‐Jones,

Oyelese

et al. 2024

Ultrasound in Obstet & Gyne

View full text Add to dashboard Cite

Toward a new standard for assessment of suspected vasa previa

Orsi,

Zaurino,

Cesano

et al. 2024

Ultrasound in Obstet & Gyne

View full text Add to dashboard Cite

In a recent publication 1 , Pozzoni et al. reviewed the diagnosis and outcome of Type-III vasa previa (VP), which is an emerging issue. Since more than 15% of Type-III VP cases did not show antenatal risk factors that could facilitate a diagnosis (e.g. abnormality of placental position or shape), the authors recommended universal VP screening between the first and second trimester. Nonetheless, we believe that some elements require further investigation. Firstly, although universal VP screening remains debated, around 85% of cases of Type-III VP are associated with placental abnormalities, especially mid-trimester low-lying placenta and marginal cord insertion 1,2 . Secondly, numerous pitfalls can make diagnosis difficult or cause it to be missed, including the traditional method of evaluation by manual lifting of the fetal head from the internal cervical os, which can be misleading 3 . Thirdly, placental tissue atrophy, possibly due to reduced vascular flow in the lower uterine segment, which is the most popular pathogenetic hypothesis of Type-III VP, has not yet been confirmed 1,4 . In regard to this scenario, we discuss the case of a patient who was admitted recently to our institution (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy) which summarizes these clinical challenges well, allowing us to formulate a proposal for a standard multi-step evaluation of patients with suspected Type-III

show abstract

Vasa previa in singleton pregnancies: diagnosis and clinical management based on an international expert consensus

Oyelese,

Javinani,

Gudanowski

et al. 2024

American Journal of Obstetrics and Gynecology

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Evolution from placenta previa to Type‐3 vasa previa

Cited by 4 publications

References 12 publications

Challenging common misconceptions in vasa previa screening and diagnosis

Challenging common misconceptions in vasa previa screening and diagnosis

Toward a new standard for assessment of suspected vasa previa

Vasa previa in singleton pregnancies: diagnosis and clinical management based on an international expert consensus

Contact Info

Product

Resources

About